TY - JOUR
T1 - Granulysin
AU - Clayberger, Carol
AU - Krensky, Alan M.
PY - 2003/10
Y1 - 2003/10
N2 - Granulysin, a molecule expressed by human natural killer cells and activated T lymphocytes, exhibits cytolytic activity against a variety of microbes and tumors. Progress in understanding the structure, function and clinical relevance of granulysin over the past year encompasses three main areas: first, the solution of its crystal structure, providing new insights into its potential mechanism of target cell damage; second, inhibition of its function with small interfering RNA, indicating its relevance in microbial immunity; and third, association of granulysin expression in natural killer cells with good outcomes in cancer, indicating its potential utility as a diagnostic and suggesting its relevance to human disease.
AB - Granulysin, a molecule expressed by human natural killer cells and activated T lymphocytes, exhibits cytolytic activity against a variety of microbes and tumors. Progress in understanding the structure, function and clinical relevance of granulysin over the past year encompasses three main areas: first, the solution of its crystal structure, providing new insights into its potential mechanism of target cell damage; second, inhibition of its function with small interfering RNA, indicating its relevance in microbial immunity; and third, association of granulysin expression in natural killer cells with good outcomes in cancer, indicating its potential utility as a diagnostic and suggesting its relevance to human disease.
UR - http://www.scopus.com/inward/record.url?scp=0141853014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141853014&partnerID=8YFLogxK
U2 - 10.1016/S0952-7915(03)00097-9
DO - 10.1016/S0952-7915(03)00097-9
M3 - Review article
C2 - 14499265
AN - SCOPUS:0141853014
SN - 0952-7915
VL - 15
SP - 560
EP - 565
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 5
ER -